Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Increased reporting of fatal immune checkpoint inhibitor-associated myocarditis.

Literature DB >> 29536852

Increased reporting of fatal immune checkpoint inhibitor-associated myocarditis.

Javid J Moslehi¹, Joe-Elie Salem², Jeffrey A Sosman³, Bénédicte Lebrun-Vignes⁴, Douglas B Johnson⁵.

Abstract

Entities: Chemical Disease Gene Species

Year: 2018 PMID： 29536852 PMCID： PMC6668330 DOI： 10.1016/S0140-6736(18)30533-6

Source DB: PubMed Journal: Lancet ISSN： 0140-6736 Impact factor: 79.321

× No keyword cloud information.

4 in total

1. PD-1 Blockers.

Authors: Jedd D Wolchok
Journal: Cell Date: 2015-08-27 Impact factor: 41.582

2. Clinical Features, Management, and Outcomes of Immune Checkpoint Inhibitor-Related Cardiotoxicity.

Authors: Marion Escudier; Jennifer Cautela; Nausicaa Malissen; Yann Ancedy; Morgane Orabona; Johan Pinto; Sandrine Monestier; Jean-Jacques Grob; Ugo Scemama; Alexis Jacquier; Nathalie Lalevee; Jeremie Barraud; Michael Peyrol; Marc Laine; Laurent Bonello; Franck Paganelli; Ariel Cohen; Fabrice Barlesi; Stephane Ederhy; Franck Thuny
Journal: Circulation Date: 2017-11-21 Impact factor: 29.690

3. Fulminant Myocarditis with Combination Immune Checkpoint Blockade.

Authors: Douglas B Johnson; Justin M Balko; Margaret L Compton; Spyridon Chalkias; Joshua Gorham; Yaomin Xu; Mellissa Hicks; Igor Puzanov; Matthew R Alexander; Tyler L Bloomer; Jason R Becker; David A Slosky; Elizabeth J Phillips; Mark A Pilkinton; Laura Craig-Owens; Nina Kola; Gregory Plautz; Daniel S Reshef; Jonathan S Deutsch; Raquel P Deering; Benjamin A Olenchock; Andrew H Lichtman; Dan M Roden; Christine E Seidman; Igor J Koralnik; Jonathan G Seidman; Robert D Hoffman; Janis M Taube; Luis A Diaz; Robert A Anders; Jeffrey A Sosman; Javid J Moslehi
Journal: N Engl J Med Date: 2016-11-03 Impact factor: 91.245

4. Cardiotoxicity associated with CTLA4 and PD1 blocking immunotherapy.

Authors: Lucie Heinzerling; Patrick A Ott; F Stephen Hodi; Aliya N Husain; Azadeh Tajmir-Riahi; Hussein Tawbi; Matthias Pauschinger; Thomas F Gajewski; Evan J Lipson; Jason J Luke
Journal: J Immunother Cancer Date: 2016-08-16 Impact factor: 13.751

4 in total

208 in total

Review 1. Cancer Treatment-Associated Pericardial Disease: Epidemiology, Clinical Presentation, Diagnosis, and Management.

Authors: Chandra K Ala; Allan L Klein; Javid J Moslehi
Journal: Curr Cardiol Rep Date: 2019-11-25 Impact factor: 2.931

Increased reporting of fatal immune checkpoint inhibitor-associated myocarditis.

1. PD-1 Blockers.

2. Clinical Features, Management, and Outcomes of Immune Checkpoint Inhibitor-Related Cardiotoxicity.

3. Fulminant Myocarditis with Combination Immune Checkpoint Blockade.

4. Cardiotoxicity associated with CTLA4 and PD1 blocking immunotherapy.

Review 1. Cancer Treatment-Associated Pericardial Disease: Epidemiology, Clinical Presentation, Diagnosis, and Management.

2. Severe Epididymo-Orchitis and Encephalitis Complicating Anti-PD-1 Therapy.

Review 3. Fundamental Mechanisms of Regulated Cell Death and Implications for Heart Disease.

Review 4. Cancer therapy-induced cardiovascular toxicity: old/new problems and old drugs.

Review 5. Cardiotoxicity of Immune Checkpoint Inhibitors.

Review 6. Harnessing cancer immunotherapy during the unexploited immediate perioperative period.

Review 7. Neuromuscular Complications of Programmed Cell Death-1 (PD-1) Inhibitors.

Review 8. Changing Hearts and Minds: Improving Outcomes in Cancer Treatment-Related Cardiotoxicity.

Review 9. Biomarkers for the detection of apparent and subclinical cancer therapy-related cardiotoxicity.

Review 10. Heart failure in cancer: role of checkpoint inhibitors.